Rick Doblin had come to believe that psychedelic experiences are the "common core" of all religions, and he wanted to test this thesis. In February 1984, the 31-year-old college student living off a trust fund in Sarasota, Florida, typed out a letter to the United Nations, proposing a study that would double as a "training program for a variety of religious ministries." He needed only 50 volunteers, he said, plus a panel of scholars and religious mystics (including His Holiness the Dalai Lama) to judge the results.
Doblin reached out to several politicians for help too. He even wrote a letter to Pope John Paul II. In the meantime, he took on what might have been an even more daunting task, though today it sounds almost mainstream: turning MDMA into medicine.
Beginning in 2015, another psychedelic visionary, Roland Griffiths, initiated a research project nearly identical to what Doblin envisioned. A collaboration between the Johns Hopkins University School of Medicine and NYU Langone Health, Griffiths' experiment gave psilocybin to two dozen "religious professionals"—Christian, Jewish, Buddhist, and Muslim clergy—on two separate occasions.
